Evaluating somatic tumor mutation detection without matched normal samples
Jamie K. Teer, Yonghong Zhang, Lu Chen et al. · Human Genomics · 2017
BACKGROUND: Observations of recurrent somatic mutations in tumors have led to identification and definition of signaling and other pathways that are important for cancer progression and therapeutic targeting. As tumor cells contain both an individual's inherited genetic variants and somatic mutations, challenges arise in distinguishing these events in massively parallel sequencing datasets. Typically, both a tumor sample and a "normal" sample from the same individual are sequenced and compared; variants observed only in the tumor are considered to be somatic mutations. However, this approach requires two samples for each individual. RESULTS: We evaluate a method of detecting somatic mutations in tumor samples for which only a subset of normal samples are available. We describe tuning of the method for detection of mutations in tumors, filtering to remove inherited variants, and comparison of detected mutations to several matched tumor/normal analysis methods. Filtering steps include the use of population variation datasets to remove inherited variants as well a subset of normal samples to remove technical artifacts. We then directly compare mutation detection with tumor-only and tumor-normal approaches using the same sets of samples. Comparisons are performed using an internal targeted gene sequencing dataset (n = 3380) as well as whole exome sequencing data from The Cancer Genome Atlas project (n = 250). Tumor-only mutation detection shows similar recall (43-60%) but lesser precision (20-21%) to current matched tumor/normal approaches (recall 43-73%, precision 30-82%) when compared to a "gold-standard" tumor/normal approach. The inclusion of a small pool of normal samples improves precision, although many variants are still uniquely detected in the tumor-only analysis. CONCLUSIONS: A detailed method for somatic mutation detection without matched normal samples enables study of larger numbers of tumor samples, as well as tumor samples for which a matched normal is not available. As sensitivity/recall is similar to tumor/normal mutation detection but precision is lower, tumor-only detection is more appropriate for classification of samples based on known mutations. Although matched tumor-normal analysis is preferred due to higher precision, we demonstrate that mutation detection without matched normal samples is possible for certain applications.
Cited by 77 works. doi:10.1186/s40246-017-0118-2 Open-access PDF
Authors
- Jamie K. Teer
- Yonghong Zhang
- Lu Chen
- Eric A. Welsh
- William Douglas Cress
- Steven A. Eschrich
- Anders Berglund
References
- Fast and accurate short read alignment with Burrows–Wheeler transform
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
- A map of human genome variation from population-scale sequencing
- BEDTools: a flexible suite of utilities for comparing genomic features
- A framework for variation discovery and genotyping using next-generation DNA sequencing data
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- An integrated map of genetic variation from 1,092 human genomes
- Analysis of protein-coding genetic variation in 60,706 humans
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing